Bonk (NASDAQ:BNKK) Downgraded to Sell Rating by Wall Street Zen

Bonk (NASDAQ:BNKKGet Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Sunday.

Separately, Weiss Ratings lowered shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on Bonk

Bonk Stock Performance

Shares of NASDAQ BNKK opened at $1.62 on Friday. The company has a 50 day simple moving average of $2.15 and a two-hundred day simple moving average of $3.11. The stock has a market cap of $12.96 million, a price-to-earnings ratio of -0.35 and a beta of 1.85. Bonk has a 12 month low of $1.25 and a 12 month high of $46.90.

Bonk (NASDAQ:BNKKGet Free Report) last released its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) earnings per share for the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.The business had revenue of $0.79 million during the quarter.

Insider Buying and Selling

In other Bonk news, Director Mitchell Austin Rudy acquired 31,055 shares of the company’s stock in a transaction on Thursday, April 9th. The shares were bought at an average cost of $2.82 per share, with a total value of $87,575.10. Following the completion of the acquisition, the director owned 44,198 shares in the company, valued at approximately $124,638.36. This trade represents a 236.29% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 51.60% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. State Street Corp acquired a new stake in Bonk in the 4th quarter valued at $33,000. Steward Partners Investment Advisory LLC purchased a new stake in Bonk in the 4th quarter worth $37,000. Jane Street Group LLC purchased a new stake in Bonk in the 4th quarter worth $96,000. Finally, Geode Capital Management LLC acquired a new position in Bonk during the fourth quarter worth $128,000. 12.55% of the stock is owned by institutional investors and hedge funds.

Bonk Company Profile

(Get Free Report)

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.

Recommended Stories

Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.